GI Dynamics, Inc. is engaged in designing, developing, and marketing medical devices for non-surgical approaches to treating type 2 diabetes and obesity. The Company operates in Chile, Germany, the United Kingdom, the Netherlands and Austria.The Company�s primary product is the EndoBarrier Gastrointestinal Liner, or implant. The implant contains an anchor and a 60 cm impermeable sleeve that lines the duodenum and jejunum. The liner is made of a fluoropolymer material and contains a radiopaque marker embedded in the proximal end of the implant to aid in deployment. The materials used in the implant are stable in this environment. EndoBarrier Therapy is a non-surgical, non-pharmaceutical treatment to help people living with uncontrolled type 2 diabetes and obesity achieve rapid and reductions in blood sugar levels, as well as substantial weight loss. The primary purpose of these devices is to alter the GI function such that improvements in glucose control and weight loss occur.